Skip to content
Search

Latest Stories

RPS urges to ensure safety of BAME healthcare workers

The Royal Pharmaceutical Society has urged the NHS and government to include pharmacy in national plans to keep BAME healthcare workers safe as they are affected more seriously by Covid-19, compared to the white population.

“We fully recognise the impact on our profession and urge the NHS and government to include pharmacy in national plans to keep BAME healthcare workers safe," Ravi Sharma, RPS Director for England, said on Thursday (7).


The pharmacy sector has a high representation of black, Asian and minority ethnic (BAME) workers, comprising 43 per cent of the workforce.

The RPS statement follows a report published by the Office for National Statistics (ONS) on Thursday that Covid-19 deaths are four times more likely among black adults than those of white ethnicity.

The ONS has noted that black males are 4.2 times more likely to die from a Covid-19-related death and black females are 4.3 times more likely than white ethnicity males and females.

"People of Bangladeshi and Pakistani, Indian, and mixed ethnicities also had statistically significant raised risk of death involving Covid-19 compared with those of white ethnicity," the report found.

Sharma added: "A disproportionate number of BAME staff work on the frontline of the NHS and have lost their lives to coronavirus, including amongst the pharmacy profession. This is devastating and is a very real reminder of the inequalities around race that still pervade our healthcare system and wider society.”

Scientists cautioned that there were vast holes in their knowledge and cite striking differences in the death rates based on age, sex and ethnicity.

Genetics, they say, might hold many clues that could help eventually reveal a path to medicines or a vaccine that could treat the disease.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less